// App-Quantinova.ai

: Antithrombotic use amongst patients at low stroke risk as defined by the CHA2DS2-VASc score: Insight from the prospective SPRINT-AF registry

Researchers

Presenter

  • A. Shuaib

Principal Investigators

  • N. Singh

  • M. Gupta

Medical Centers

  • University of Alberta, Medicine, Edmonton, Canada

  • Medical College of Georgia at Augusta university, Medicine, Augusta, United States of America

  • McMaster University, Internal Medicine, Hamilton, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Observational

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved